Even as India expands its inoculation campaign to include all adults, its COVID-19 vaccine options are expected to increase. The first shipment of the world’s first vaccine, Russia’s Sputnik V, is expected to arrive in Hyderabad on May 1. Developed by the Gamaleya Institute in Moscow and billed as the world’s first COVID-19 vaccine, it is also the third vaccine to gain approval for emergency use in India. .

Although no official details have been received on the number of doses present in this tranche, the ANI news agency quoted diplomatic sources to say that India expects to receive 150,000 to 200,000 vaccines ready. for employment which will be available very quickly at the beginning of May. . There are reports that 3 million additional doses are expected by the end of the month.

India is expected to receive 5 million doses of the vaccine by June. In April, the CEO of the Russian Direct Investment Fund, Kirill Dmitriev, confirmed that the first batch would arrive on May 1 and said he expected more than 50 million doses of the vaccine to be manufactured in India. over the next few months. Earlier reports had indicated that five Indian pharmaceutical companies had been contracted to produce 850 million doses per year.

Sputnik V should be administered in two doses of 0.5 ml each with an interval of 21 days. According to the guidelines, the vaccine is indicated for active immunization to prevent Covid-19 in people over the age of 18 and it should be stored at a temperature of minus 18 degrees Celsius in liquid form. However, it can be kept at a temperature of 2-8 degrees Celsius in its freeze-dried form in a conventional refrigerator, making it easy to transport and store.

Sputnik V demonstrated an efficacy rate of 91.6% in the interim analysis of the Phase 3 clinical trial, which included data from 19,866 volunteers in Russia. Manufacturers insist that the vaccine offers complete protection against severe cases of COVID-19 and that there are no strong allergies caused by Sputnik V.

Earlier today, people between the ages of 18 and 44 began to queue for the first time outside COVID-19 vaccination centers in various parts of India. But even as India’s vaccination efforts have intensified, many hospitals and state governments have reported shortages. In Mumbai, for example, the BMC is running the vaccination campaign in just five centers, after issuing an advisory that only those who receive messages will receive the vaccine. The arrival of a third vaccine will in turn give new impetus to vaccination efforts.

(With contributions from agencies)